Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Sponsored ContentThis is not an endorsement from the ABTA. Endre Hudy has accomplished a lot in the past five years: He completed an MBA, became a U.S. citizen, launched a new career
Sponsored ContentThis is not an endorsement from the ABTA. The IGNITE clinical research study is evaluating an investigational study drug in adults who have primary central nervous system lymphoma (PCNSL)
By Michelline, Novocure Patient Ambassador Life with GBM Hi, my name is Michelline, and I have glioblastoma (GBM). I want to share how my diagnosis has strengthened my relationships, reshaped my goals, and helped me remain
By Amanda Saratsis, MD, FAANS, FCNS – Senior Director, Global Medical Affairs, Oncology, Jazz Pharmaceuticals Each May, Brain Cancer Awareness Month highlights brain and other central nervous system cancers—some of the most complex and
In April 2022, everything changed when Neil Manausa was diagnosed with primary central nervous system lymphoma (PCNSL). It began subtly, his left leg started dragging, and he gradually lost peripheral
Sponsored Content On December 2, 2025, Imvax, Inc. announced top-line results from a Phase 2b clinical trial of IGV-001, an investigational autologous biologic-device combination product, in 99 adults with newly
When facing a diagnosis of glioma or glioblastoma (GBM), every scan, symptom and decision can feel deeply personal. Patients and families quickly learn how much depends on imaging — it
Always free for patients & caregivers
